Clearmind Medicine Inc.

CMND | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.78

-$0.01 (-1.34%)

At close: Sep 22, 2026, 4:00 PM ET

$0.79

+$0.01 (+0.77%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.17M

Enterprise Value $-12.96M

Beta -1.22

Average Volume 1.6M

Shares Outstanding (Diluted) 1.58M

Shares Change YoY 18.47%

Institutional Ownership 1.49%

Exchange NASDAQ

ISIN CA1850536006

Price Performance

Price Change 1M -54.1%

Price Change 3M -73.4%

Price Change 6M -89.0%

Price Change YTD -96.0%

Price Change 1Y -99.8%

Price Change 3Y -100.0%

Price Change 5Y -100.0%

1M CAGR (ann.) -51.5%

1Y CAGR (ann.) -99.8%

5Y CAGR (ann.) N/A

All-Time CAGR -94.8%

Valuation

PE Ratio -0.07

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS N/A

PB Ratio 0.09

P/FCF Ratio -0.16

P/Adj. FCF Ratio -0.13

P/OCF Ratio -0.17

EV/Sales N/A

EV/EBIT 1.56

EV/EBITDA 1.57

EV/FCF 1.72

Earnings Yield -1411.4%

FCF Yield -641.8%

Adj. FCF Yield -776.0%

Financial Health

Net Cash $14.23M

Total Debt $1.8M

Cash & Short-Term Investments $15.93M

Total Assets $16.91M

Current Ratio 4.31

Quick Ratio 4.31

Debt / Equity Ratio 0.14

Debt / EBITDA -0.22

Debt / FCF -0.24

OCF / Debt -4.19

Interest Coverage -649.82

Altman Z-Score -3.40

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -20.9%

Returns

Return on Assets -44.3%

Return on Equity -87.3%

Return on Invested Capital -60.1%

Return on Capital Employed -67.9%

Return on Tangible Assets -44.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 92.8%

EPS CAGR 5Y 80.4%

EPS CAGR 10Y N/A

FCF CAGR 3Y -12.9%

FCF CAGR 5Y -10.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Sep 9, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-7.54M

Free Cash Flow $-7.54M

Adj. Free Cash Flow $-9.11M

FCF Per Share -$4.76

OCF Per Share -$4.76

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-54.27K

Operating Income $-8.86M

EBITDA $-8.23M

Net Income $-7.49M

EPS (Diluted) -$11.15

Revenue / Employee N/A

Profit / Employee $-1.87M

Employees 4